Concepedia

Ellen M. Apperloo

EM

6

Publications

239

Citations

6

H-Index

2018

Active since

Affiliations

University of Groningen(Current)

University Medical Center Groningen

University of Toronto

Comprehensive Cancer Center Erlangen

Universitätsklinikum Erlangen

Ellen M. Apperloo is an author at University of Groningen specializing in clinical trials, metabolic syndrome, and diabetes.

ORCID

Top concepts

Publications per year

2018–2025

6

Publications

6

Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials

Hiddo J.L. Heerspink, Ellen M. Apperloo, Melanie J. Davies et al. · Diabetes Care · 2023 · 86 citations · Full text

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

Ellen M. Apperloo, José Luis Górriz, María José Soler et al. · Nature Medicine · 2024 · 76 citations · Full text

, , +9

Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Clinical Trials

Ellen M. Apperloo, Katherine R. Tuttle, Imre Pávó et al. · Diabetes Care · 2025 · 30 citations · Full text

Albuminuria‐lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross‐over clinical study

Annemarie B. van der Aart‐van der Beek, Ellen M. Apperloo, Niels Jongs et al. · Diabetes Obesity and Metabolism · 2023 · 24 citations · Full text

Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6

Ellen M. Apperloo, David Z.I. Cherney, Anja Birk Kuhlman et al. · Nephrology Dialysis Transplantation · 2024 · 13 citations · Full text

Rows per page

1–5 of 6